This study intends to conduct research on the relationship between <i>CYP2C19</i> polymorphisms ((rs4244285, 681G > A, *2) and (rs4986893, 636G > A, *3)) and the risk of CAS in patients with T2DM. This evidence concerns the gene CYP2C19 and type 2 diabetes mellitus.